T. Rowe Price Associates »

Vincera Pharma shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Vincera Pharma (VINC) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Vincera Pharma

Tip: Access up to 7 years of quarterly data

All positions including Vincera Pharma held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vincera Pharma by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $48k 40k 1.20
2023-09-30 $42k 40k 1.05

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
Nvidia Corporation Comm Stk (NVDA)
Meta Platforms Comm Stk (META)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Unitedhealth Group Comm Stk (UNH)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Intuit Comm Stk (INTU)
Servicenow Comm Stk (NOW)
Fiserv Comm Stk (FI)

View all positions for T. Rowe Price Associates

Top funds holding Vincera Pharma

Goldman Sachs Group
Sage Rhino Capital
Long Focus Capital Management
Bank of America Corporation
Vanguard Group
Kingdon Capital Management
Point72 Asset Management
Tejara Capital
Citadel Advisors
Walleye Trading Advisors
Schonfeld Strategic Advisors
T. Rowe Price Associates
Millennium Management
GW & Wade
LMR Partners

View all funds holding Vincera Pharma